Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Gastrointestinal haemorrhage Age: Adult |
Dose: Intravenous – 250 micrograms Frequency: initially as a bolus injection over 3-5 minutes Note: followed by a continuous infusion of 3.5 micrograms/kg/hour until bleeding has ceased |
|
Indication: Gastrointestinal haemorrhage Age: Adult Condition: To prevent recurrent bleeding |
Dose: Intravenous – 3.5 micrograms/kg/hour Frequency: continuous infusion Duration: further 48-72 hours |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: Not recommended |
Administration
- Given by IV infusion
- Requires continuous monitoring
Side Effect
- Rapid infusion may lead to abdominal discomfort, nausea, flushing, bradycardia
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Hexobarbital
|
Lengthens the time of hexobarbital-induced sleep
|
|
Pentetrazol
|
Potentiates the action of pentetrazol
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Storage condition and expiry date are indicated on the box. Solutions of Somatostatin in physiological sodium chloride are stable for 24 hours.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.